Health
Can glucose-lowering drugs impact mortality in COVID-19 patients with type 2 diabetes? – EurekAlert
Peer reviews of a new study examining the relationship between Type 2 Diabetes and COVID-19 say the research is reliable and relevant, but also call for further…
CAMBRIDGE, MA – October 27, 2020– In a preprint paper, “Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19,” researchers conclude a neutral effect on mortality and other adverse outcomes. Though, given the close relationship between diabetes and COVID-19, they call for more prospective studies.
In their peer reviews of the study, Susanna Hofmann (Division Head, Helmholtz Diabetes Center) and Tamaryn Fox (Internal Medicine,…
Continue Reading
